However, viruses can become resistant in immunosuppressed patients and in patients with acquired immunodeficiency syndrome. [3] [4] [5] [6] Because such ACV-resistant viruses are also resistant to other nucleoside analogs, new therapeutic agents with a different mode of anti-HSV action are required.
Many natural products can inhibit viruses. Natural marine products contain an abundance of biologically active substances with novel chemical structures and favorable pharmacological activities. 7) Marine organisms are also a promising source of antiviral compounds. 8) Several investigators have described the inhibitory effects of algal extracts and their constituents on the replication of herpes simplex viruses. [9] [10] [11] Serkedjieva 12) recently found that a water extract of Polysiphonia denudata (Rhodomelaceae) prevents HSV-1 reproduction by inhibiting viral adsorption to susceptible cells as well as viral synthetic stages.
The present paper describes the antiviral activity of MeOH extracts of seaweeds collected in Korea, their fractions and constituents. Furthermore, the therapeutic efficacy of some anti-HSV compounds isolated from Symphyocladia latiuscula (Rhodomelaceae) in vitro was evaluated in an experimental animal model in vivo.
MATERIALS AND METHODS

Viruses and Cells
We propagated wild type 7401H HSV-1, 13) thymidine kinase-deficient (TK Ϫ ) HSV-1 (B2006) 14) and acyclovir (ACV) and phosphonoacetic acid (PAA)-resistant AP r HSV-1 15, 16) in Vero E6 cells. The infected cultures were frozen and thawed three times, centrifuged at 1650ϫg for 15 min and then supernatants were stored at Ϫ80°C. 17) Vero cells were cultured and maintained in Eagle's minimal essential medium (MEM) supplemented with 5% and 2% calf serum, respectively.
Algal Materials Five varieties of seaweed collected at Chunsapo (Pusan, Korea) were washed with water, dried in the shade and then deposited at the Department of Food Science and Nutrition, Pukyong National University for authentication by Prof. K.W. Nam (Department of Marine Biology, Pukyong National University).
Extraction and Purification Dried seaweeds (10 g each) were pulverized and extracted three times with MeOH (20 ml). The solvent was removed under reduced pressure to yield the respective extracts (1.7 g from Ecklonia stolonifera, (Laminariae), 1.4 g from Sargassum ringoldianum (Sargassaceae), 1.2 g from Sargassum thunbergii (Sargassaceae), 2.0 g from Symphyocladia latiuscula and 1.6 g from Ulva pertusa (Ulvaceae)).
The MeOH extract of S. latiuscula (147 g) was successively extracted three times each with IL of hexane, dichloromethane (CH 2 CH 2 ), ethyl acetate and butanol to yield the respective soluble fractions together with a residual water-soluble fraction, in yields of 14. The antiviral activities of extracts from 5 species of marine algae collected at Haeundae (Pusan, Korea), were examined using plaque reduction assays. Although the activity of a methanol (MeOH) extract of Sargassum ringoldianum (Sargassaceae) was the most potent against several types of viruses, it was also cytotoxic. The CH 2 CH 2 -soluble fraction (21 g) was eluted through a column containing silica gel using a CH 2 CH 2 -MeOH gradient. Fractions 5-9 (5.76 g) were further eluted through silica gel using CH 2 Cl 2 -MeOH (10 : 1) to yield 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (TDB) (1, 2.82 g) in the order of increasing polarity. Fractions 4 (1.2 g) and 12 (0.8 g) were further separated by silica-gel column chromatography using CH 2 Cl 2 -MeOH (10 : 1 and 5 : 1) to yield symphyoketon [(2R)-2-(2,3,6-tribromo-4,5-dihydroxybenzyl)cyclohexanone] (3, 6.5 mg) and 2,3,6-tribromo-4,5-dihydroxybenzyl alcohol (2, 2.5 mg), respectively as described. 18, 19) The spectroscopic data of these compounds matched those of authentic samples. The compounds were chromatographically homogeneous when determined by HPLC, dissolved in dimethyl sulfoxide (DMSO) and used for the following assays, in which the final concentration of DMSO was 0.01%.
Acyclovir Acyclovir (ACV) was purchased as tablets from Nippon Wellcome K.K. One tablet (200 mg) was powdered and suspended in distilled water to give an appropriate concentration.
Plaque Reduction Assay Duplicate cultures of Vero cells in 60 mm plastic dishes were infected with 100 plaqueforming units (PFU)/0.2 ml of HSV-1 (7401H strain), AP r HSV-1 and TK Ϫ HSV-1 for 1 h. The cells were then overlaid with 5 ml of nutrient methylcellulose (0.8%) medium containing 100 mg/ml of seaweed-extracts and incubated for 3 d at 37°C. The cells were fixed and stained, and then the number of plaques was counted. 20) The anti-HSV activity of each test sample was determined as the ratio (%) of plaque formation compared with the control as follows: % Plaque formationϭ100ϫ[number of plaques (test sample)/number of plaques (control)]. The inhibitory concentration required for 50% plaque reduction (IC 50 ) was determined from a curve relating plaque number to the concentration of a sample.
The cytotoxicity of seaweed extracts and their fractions was evaluated as the extent of uninfected cells that were omitted from the surface of stained dishes in the plaque reduction assay (visible cytotoxicity) and compared with that of a control. Results were recorded as follows: (Ϫ) no cell detachment, (Ϯ) thick coloration of cell layer (less than 10% cell detachment), (ϩ) 10-50% cell detachment, (ϩϩ) over 50% cell detachment and (ϩϩϩ) complete cell detachment. The cytotoxicity of compounds was determined as the inhibition of Vero cell growth. 13) Briefly, Vero cells were seeded at a density of 5ϫ10 4 cells/well in 24-well plates and incubated at 37°C for 2 d. The culture medium was replaced with fresh medium containing test compounds at various concentrations, and the cells were further incubated for 2 d. The cells were lysed with trypsin and the number of viable cells was determined by Trypan blue exclusion. The concentrations of test compounds that reduced cell viability by 50% (CC 50 ) were determined from a curve relating % cell viability to the TDB concentration.
Therapeutic Efficacy in a Mouse HSV-1 Infection Model Female BALB/c mice (6-weeks-old) were purchased from Sankyo Labo Service Co., Ltd. (Tokyo, Japan). The right midflank of each mouse was clipped and chemically depilated with Hair Remover (Shiseido, Co., Ltd., Tokyo, Japan). One or two days later, the exposed skin was scratched using a 27-gauge needle and 10 ml of HSV-1 (7401H strain) suspension containing 1ϫ10 6 PFU was applied to the area. 21, 22) At that time, the MeOH extract of S. latiuscula (5 mg/mouse; 200 mg/kg) and TDB (0.5 mg/ mouse; 20 mg/kg) were orally administered in a volume of 0.25 ml/mouse once at 4 h before, and three times daily for 6-10 successive days after HSV injection. The development of skin lesions and mortality were continuously monitored every 8 h and scored as follows: 0, no lesion; 2, local vesicles; 4, local erosion and/or ulceration; 6, mild zosteriform lesion; 8, moderate zosteriform lesion; 10, severe zosteriform lesion; death. Cutaneous infection with a 7401H HSV-1 strain is a lethal model that causes skin lesions and death in the mice. Student's t-test evaluates the significance of differences between controls and the groups treated with MeOH extract and with TDB with respect to mean survival times and mean times at which skin lesions were initially scored as 2 or 6 after infection. ACV was used as the positive control.
Determination of Virus Yields in Skin and Brain Virus yields in the skin and brain were determined in infected mice. Mice were cutaneously infected with wild-type 1 HSV, and the MeOH extract and TDB from S. latiuscula were orally administered at doses of 5 and 0.5 mg/kg, respectively, according to the schedule described above. The brain and skin [whole lesions that included a 5ϫ5 mm area encompassing the inoculation site] were removed under ether anesthesia on days 3 and 6 after infection and homogenized in 2 ml of PBS. The homogenate was centrifuged at 1650ϫg for 15 min and the virus yield in the supernatant was determined on Vero cells by plaque assays.
13)
RESULTS
Effects of MeOH Extracts from Various Seaweeds on Plaque Reduction
To evaluate the antiviral activity of MeOH extracts of 5 species of seaweeds, we examined their ability to inhibit plaque formation by wild type HSV-1, AP r HSV-1 and TK Ϫ HSV-1 (Table 1) . Plaque formation by the three virus strains was absent in cells exposed to the Sargas- Anti-HSV Activity of Various Fractions Obtained from S. latiuscula To investigate the active principles, the S. latiuscula extract was successively partitioned with hexane, CH 2 Cl 2 , ethyl acetate and butanol to yield the respective fractions. Plaque formation assays showed that the CH 2 Cl 2 -soluble fraction was the most active (IC 50 value of 7.73 mg/ml (Chart 1)). Anti-HSV activities were positive in the order of CH 2 Cl 2 ϾhexaneϾethyl acetateϾbutanol and residual watersoluble fractions.
Anti-HSV Activity of Compounds Isolated from a CH 2 Cl 2 -Soluble Fraction We isolated 2,3,6-tribromo-4,5-dihydroxybenzyl methyl ether (TDB), 2,3,6-tribromo-4,5-dihydroxybenzylalcohol (TDBA), and (2R)-2-(2,3,6-tribromo-4,5-dihydroxybenzyl)cyclohexanone (symphyoketon) from the CH 2 Cl 2 -soluble fraction and identified their chemical structures using physical and spectral means. 18, 19) The IC 50 values of symphyoketon, TDB, and TDBA were 4.11, 3.02 and 7.82 mg/ml, respectively, against the wild-type HSV-1 strain according to the plaque reduction assay ( Table 2 ). The CC 50 values (cytotoxicity) of TDB and TDBA were Ͼ100 and 78.53 mg/ml, respectively (the CC 50 value of symphyoketon was not determined).
The anti-viral activities of these compounds were compared among three HSV-1 strains (wild type HSV-1, AP r HSV-1 and TK Ϫ HSV-1) to determine their modes of anti-HSV action. All three strains were similarly susceptible to TDB and TDBA. The inhibitory activity of these bromophenolic compounds was higher than that of positive control ACV against HSV-1 mutant strains, AP r HSV-1 and TK Ϫ HSV-1. Thus, these compounds were novel antiviral agents against AP r HSV-1 and TK Ϫ HSV-1 strains, as well as wildtype HSV-1 strains.
Therapeutic Efficacies of an MeOH Extract and TDB from S. latiuscula on a Mouse HSV-1 Infection Model
Although the MeOH extract at both tested concentrations had significant therapeutic efficacy in the preliminary experiment, the mortality rates were higher and survival periods were lower at 10, than at 5 mg/mouse (data not shown). The maximal dose of the MeOH extract was established at 5 mg/mouse, and through bioassay-guided fractionation, the anti-HSV activity of TDB was maximal at 0.5 mg/mouse, was 10-fold lower than that of the MeOH extract (Table 3) .
Following the oral administration of 5 mg/mouse of the extract or 0.5 mg/mouse of TDB, the mean weight of these mice compared with that of the control did not significantly differ, indicating that the active compound was not toxic at these doses. Figure 2 shows that the oral administration of TDB and the extract significantly delayed the development of skin lesions compared with the control (pϽ0.05 by Student's t-test). This tendency was similar to that of the positive control using ACV.
Effect of MeOH Extract of S. latiuscula and TDB on Virus Yields in the Skin and Brain of Infected Mice
We evaluated the anti-HSV-1 activities of both the MeOH extract and of TDB along with virus yields in the skin and brain of HSV-1 infected mice. Table 4 shows the virus yields in the skin and brain removed from mice 3 and 6 d after infection 2260 Vol. 28, No. 12 and treated with the MeOH extract and TDB at doses of 5.0 and 0.5 mg/mouse, respectively. Both compounds significantly reduced virus yield in the skin compared with the control and tended to decrease virus yield in the brain, but the reduction did not reach significance.
DISCUSSION
Many investigators have reported the inhibitory effects of algal extracts and their constituents on the replication of herpes simplex viruses. Deig et al. 8) reported that aqueous extracts of Farlowia mollis and Cryptosiphnia woodii significantly interfere with HSV-1 reproduction. Ehresmann et al. 9) studied the virus-inhibitory activities of 28 extracts from marine algae and found that 10 species of Rhodophyta contained substances that significantly reduced HSV-1 infectivity. Anderson et al. 10) obtained extracts from 25 marine organisms collected along the Swedish coast and found that the chloroform extract of Fucus seratus and the petroleum ether extract of Laminaria digitata inhibited plaque formation by HSV-1 at a concentration of 100 mg/ml without toxicity. Hayashi et al. 11) assayed 49 extracts from algae and found that among 25 aqueous fractions with anti-HSV activity, 4 were highly potent. Algal extracts reportedly inhibit plaque formation by herpes virus by through blocking viral adsorption.
9) Serkedjieva et al. 12) found that the water extract of Polysiphonia denudata reduced HSV-1 reproduction by inhibiting viral adsorption to cells as well as viral synthetic stages.
Algae contain large amounts of cell wall polysaccharides. Several sulfated polysaccharides, such as heparin, dextran sulfate, pentosan polysulfate, mannan sulfate cyclodextrins and others, inhibit the replication of various enveloped viruses, including herpes simplex virus (HSV), human cytomegalovirus (HCMV) and human immunodeficiency virus (HIV). 23) Although mechanistic studies have generated contradictory results, their mode of action has often been attributed to a blockade of the early stages of the virus replication cycle. 24) Carrageenans of diverse structural types isolated from the red seaweed Gigartina skottsbergii, potently and selectively inhibit HSV types 1 and 2 in plaque reduction assays in Vero cells. 25) These compounds are effective against clinical isolates of HSV-1 and HSV-2 as well as against ACVresistant variants.
To develop new anti-viral agents from algae, we investigated the anti-HSV-1 activities of MeOH extracts from seaweeds that are widely available in Korea, Japan and China, where they have been consumed as foodstuffs for generations.
Here, we screened the anti HSV-1 activities of MeOH extracts from five types of seaweed. We found that the CH 2 Cl 2 -soluble fraction of the MeOH extract of Symphyocladia latiuscula (HARVEY) YAMADA potently inhibited plaque formation. A hexane-soluble fraction also had powerful anti-HSV activity compared with all other extracts except the CH 2 Cl 2 -soluble fraction. Mostly bromophenols were isolated from these two fractions but the amounts and varieties were greater in the CH 2 Cl 2 -than in the hexane-soluble fraction.
S. latiuscula is a member of the family Rhodomelaceae, and it belongs to the order Ceramiales.
26) The major constituents of this alga are bromophenols (such as 2,3-dibromo-4,5-dihydroxybenzylalcohol) that are known antioxidants and antimicrobial agents. 27, 28) However, this is the first report to demonstrate the anti-viral activities of this alga.
We showed here that the MeOH extract of S. latiuscula had anti-AP r HSV-1, TK Ϫ HSV-1 and wild type HSV-1 activities in vitro ( type HSV-1 in vivo (Tables 3, 4) . The extract was effective against ACV-resistant strains, indicating that its mode of action differs from that of ACV (Table 2 ). The bromophenolic compounds isolated from S. latiuscula had anti-viral activity against AP r HSV-1 and TK Ϫ HSV-1, as well as wild-type HSV-1 strains and were more effective against the two mutant strains than ACV (positive control). These results support the notion that the seaweed extracts exert anti-viral activities through a different mechanism from that of ACV (Table 3) .
We demonstrated that the MeOH extract of S. latiuscula had appreciable oral therapeutic efficacy at a dose of 600 mg/kg (200 mg/kg, 3 times per day) in mice, which was as effective as ACV at a dose of 4 mg/kg. The MeOH extract caused no major adverse effects throughout the study. Fractionation of the MeOH extract yielded TDB, which exhibited therapeutic efficacy at a dose of 20 mg/kg in HSV-1 infected mice without apparent adverse effects (Table 3 , Fig. 2 ). At this dose, TDB was not toxic to the mice. This tendency was similar to that of the positive control, ACV (Fig. 2) . The MeOH extract and TDB significantly reduced virus yields in the skin compared with the control. Although ACV reduces virus yields more effectively in the skin than in the brain of infected mice, 15) TDB was similar in terms of effectiveness at both sites.
In conclusion, the S. latiuscula extract and its constituents (bromophenols) might provide a basis for developing new anti-HSV-1 agents that would be effective against ACV-resistant strains.
